These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

160 related items for PubMed ID: 19216096

  • 1. Correlation of electroretinography b-wave absolute latency, plasma levels of human basic fibroblast growth factor, vascular endothelial growth factor, soluble fatty acid synthase, and adrenomedullin in diabetic retinopathy.
    Zakareia FA, Alderees AA, Al Regaiy KA, Alrouq FA.
    J Diabetes Complications; 2010; 24(3):179-85. PubMed ID: 19216096
    [Abstract] [Full Text] [Related]

  • 2. Plasma vascular endothelial growth factor, angiopoietin-2, and soluble angiopoietin receptor tie-2 in diabetic retinopathy: effects of laser photocoagulation and angiotensin receptor blockade.
    Lip PL, Chatterjee S, Caine GJ, Hope-Ross M, Gibson J, Blann AD, Lip GY.
    Br J Ophthalmol; 2004 Dec; 88(12):1543-6. PubMed ID: 15548809
    [Abstract] [Full Text] [Related]

  • 3. Plasma VEGF and soluble VEGF receptor FLT-1 in proliferative retinopathy: relationship to endothelial dysfunction and laser treatment.
    Lip PL, Belgore F, Blann AD, Hope-Ross MW, Gibson JM, Lip GY.
    Invest Ophthalmol Vis Sci; 2000 Jul; 41(8):2115-9. PubMed ID: 10892852
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin converting enzyme inhibiting therapy is associated with lower vitreous vascular endothelial growth factor concentrations in patients with proliferative diabetic retinopathy.
    Hogeboom van Buggenum IM, Polak BC, Reichert-Thoen JW, de Vries-Knoppert WA, van Hinsbergh VW, Tangelder GJ.
    Diabetologia; 2002 Feb; 45(2):203-9. PubMed ID: 11935151
    [Abstract] [Full Text] [Related]

  • 5. [Changes of plasma endothelin-1 and vascular endothelial growth factor in diabetic retinopathy and the clinical application value thereof].
    Zhu H, Shi CH.
    Zhonghua Yi Xue Za Zhi; 2007 Oct 30; 87(40):2837-9. PubMed ID: 18167288
    [Abstract] [Full Text] [Related]

  • 6. Electrophysiological changes, plasma vascular endothelial growth factor, fatty acid synthase, and adhesion molecules in diabetic neuropathy.
    Zakareia FA.
    Neurosciences (Riyadh); 2008 Oct 30; 13(4):374-9. PubMed ID: 21063365
    [Abstract] [Full Text] [Related]

  • 7. VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation.
    Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K.
    Am J Gastroenterol; 2001 Mar 30; 96(3):822-8. PubMed ID: 11280558
    [Abstract] [Full Text] [Related]

  • 8. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy.
    Amin RH, Frank RN, Kennedy A, Eliott D, Puklin JE, Abrams GW.
    Invest Ophthalmol Vis Sci; 1997 Jan 30; 38(1):36-47. PubMed ID: 9008628
    [Abstract] [Full Text] [Related]

  • 9. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy.
    Mathews MK, Merges C, McLeod DS, Lutty GA.
    Invest Ophthalmol Vis Sci; 1997 Dec 30; 38(13):2729-41. PubMed ID: 9418725
    [Abstract] [Full Text] [Related]

  • 10. Relationship between circulating serum soluble interleukin-6 receptor and the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in multiple myeloma.
    Alexandrakis MG, Passam FH, Boula A, Christophoridou A, Aloizos G, Roussou P, Kyriakou DS.
    Ann Hematol; 2003 Jan 30; 82(1):19-23. PubMed ID: 12574959
    [Abstract] [Full Text] [Related]

  • 11. Angiogenic factors: vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (b-FGF) are not necessarily elevated in patients with advanced renal cell carcinoma.
    Edgren M, Lennernäs B, Larsson A, Kälkner KM.
    Anticancer Res; 2001 Jan 30; 21(2B):1423-9. PubMed ID: 11396226
    [Abstract] [Full Text] [Related]

  • 12. Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density.
    Hague S, Zhang L, Oehler MK, Manek S, MacKenzie IZ, Bicknell R, Rees MC.
    Clin Cancer Res; 2000 Jul 30; 6(7):2808-14. PubMed ID: 10914728
    [Abstract] [Full Text] [Related]

  • 13. High vitreous concentration of vascular endothelial growth factor in diabetic patients with proliferative retinopathy using statins.
    Liinamaa MJ, Savolainen MJ.
    Ann Med; 2008 Jul 30; 40(3):209-14. PubMed ID: 18382886
    [Abstract] [Full Text] [Related]

  • 14. Plasma and urinary vascular endothelial growth factor and diabetic nephropathy in Type 2 diabetes mellitus.
    Kim NH, Kim KB, Kim DL, Kim SG, Choi KM, Baik SH, Choi DS, Kang YS, Han SY, Han KH, Ji YH, Cha DR.
    Diabet Med; 2004 Jun 30; 21(6):545-51. PubMed ID: 15154937
    [Abstract] [Full Text] [Related]

  • 15. Clinical factors related to the aqueous levels of vascular endothelial growth factor and hepatocyte growth factor in proliferative diabetic retinopathy.
    Shinoda K, Ishida S, Kawashima S, Wakabayashi T, Uchita M, Matsuzaki T, Takayama M, Shinmura K, Yamada M.
    Curr Eye Res; 2000 Aug 30; 21(2):655-61. PubMed ID: 11148602
    [Abstract] [Full Text] [Related]

  • 16. Expression of vascular endothelial growth factor in proliferative diabetic retinopathy.
    Merlak M, Kovacević D, Balog T, Marotti T, Misljenović T, Mikulicić M, Dekaris I.
    Coll Antropol; 2008 Oct 30; 32 Suppl 2():39-43. PubMed ID: 19138004
    [Abstract] [Full Text] [Related]

  • 17. Role of soluble vascular endothelial growth factor receptor-1 in the vitreous in proliferative diabetic retinopathy.
    Matsunaga N, Chikaraishi Y, Izuta H, Ogata N, Shimazawa M, Matsumura M, Hara H.
    Ophthalmology; 2008 Nov 30; 115(11):1916-22. PubMed ID: 18718666
    [Abstract] [Full Text] [Related]

  • 18. Growth factors and diabetic retinopathy.
    Paques M, Massin P, Gaudric A.
    Diabetes Metab; 1997 Apr 30; 23(2):125-30. PubMed ID: 9137900
    [Abstract] [Full Text] [Related]

  • 19. Study of the association of adrenomedullin and basic-fibroblast growth factors with the peripheral arterial blood flow and endothelial dysfunction biomarkers in type 2 diabetic patients with peripheral vascular insufficiency.
    Alrouq FA, Al-Masri AA, Al-Dokhi LM, Alregaiey KA, Bayoumy NM, Zakareia FA.
    J Biomed Sci; 2014 Oct 07; 21(1):94. PubMed ID: 25287126
    [Abstract] [Full Text] [Related]

  • 20. Plasma levels of adrenomedullin, a vasoactive peptide, in type 2 diabetic patients with and without retinopathy.
    Caliumi C, Balducci S, Petramala L, Cotesta D, Zinnamosca L, Cianci R, Di Donato D, Vingolo EM, Fallucca F, Letizia C.
    Minerva Endocrinol; 2007 Jun 07; 32(2):73-8. PubMed ID: 17557032
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.